Associate Professor of Medicine, Brown University
Nephrology
Dr. Douglas G. Shemin, MD
|
|
Give Review
Douglas G. Shemin, MD is an expert in the field of Nephrology. He graduated from Case Western Reserve University School of Medicine. He received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Douglas Shemin is a published MD as well. He has 51 publications published. The latest was: Lower fasting total plasma homocysteine levels in stable renal transplant recipients versus maintenance dialysis patients. He is registered with Medicare and accepts Medicare payments.
Publications
- Hyperhomocysteinemia and traditional cardiovascular Disease risk factors in end-stage renal Disease patients on dialysis: a case-control study.
- Mechanism of porphobilinogen synthase. Requirement of Zn2+ for enzyme activity.
- On the impact on biochemical research of the discovery of stable isotopes: the outcome of the serendipic meeting of a refugee With the discoverer of heavy isotopes at ...
- A risk factor for AIDS Nephropathy.
- Acute renal failure in pregnancy. Management depends upon cause, but dialysis may be necessary.
- An illustration of the use of isotopes: the biosynthesis of porphyrins.
- Unexplained pleural effusions in the peritoneal dialysis population.
- Pheochromocytoma presenting as rhabdomyolysis and Acute myoglobinuric renal failure.
- Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal Failure.
- Abnormalities of lipoprotein Metabolism in the nephrotic syndrome.
- Serum creatinine concentration at the onset of uremia: higher levels in black males.
- The role of isotopes in the elucidation of some metabolic processes.
- Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early Acute kidney injury.
- Lupus Nephritis mimicking pyeloNephritis in pregnancy.
- Gram negative rod peritonitis in peritoneal dialysis.
- Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.
- David Rittenberg.
- Dialysis in pregnant women with chronic Kidney disease.
- A multicenter, prospective, randomized, comparative evaluation of dual- versus triple-lumen catheters for hemodialysis and apheresis in 485 patients.
- Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk Kidney transplant recipients.
- The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study.
- Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.
- Prevalence of protein malnutrition in children maintained on peritoneal dialysis.
- Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
- Treatment of mild hyperhomocysteinemia in Renal transplant recipients versus hemodialysis patients.
- Survival of a human immunodeficiency patient with nucleoside-induced lactic Acidosis--role of haemodialysis treatment.
- Effect of aminoglycoside use on residual Renal function in peritoneal dialysis patients.
- Plasma total homocysteine and hemodialysis access thrombosis: a prospective study.
- Clinical outcome in three patients With postpartum hemolytic uremic syndrome treated With frequent plasma exchange.
- Lower fasting total plasma homocysteine levels in stable Renal transplant recipients versus maintenance dialysis patients.
- Elevated fasting total plasma homocysteine levels and cardiovascular Disease outcomes in maintenance dialysis patients. A prospective study.
- Sodium balance in renal Failure.
- Gram-negative peritonitis in peritoneal dialysis: improved outcome With intraperitoneal ceftazidime.
- Treatment of hyperhomocysteinemia in end-stage renal Disease.
- Residual Renal function and mortality risk in hemodialysis patients.
- Treatment of hyperhomocysteinemia in hemodialysis patients and Renal transplant recipients.
- Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
- First hemodialysis access selection varies With patient acuity.
- Residual Renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition.
- Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.
- Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
- High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients.
- Lack of effect of oral N-acetylcysteine on the Acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients.
- Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on Chronic folic acid supplemen...
- Proliferative Glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma.
- Renal osteodystrophy and dialysis artifacts as indicators of identification.
- Antihypertensive therapy and progression of Chronic renal disease.
- Outcome data on pediatric dialysis patients from the end-stage renal Disease clinical indicators project.
- Use of amino acid peritoneal dialysate for one year in a child on CCPD.
- Clinical morbidity in pediatric dialysis patients: data from the Network 1 Clinical Indicators Project.
Schools
Case Western Reserve University School of Medicine
Rhode Island Hospital
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute GlomeruloNephritis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
SUNY Health Science Center at Brooklyn -
Brown University -
Brown University Affiliated Hospitals -
Case Western Reserve University School of Medicine
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1710934724 | |
| NPPES Provider LastName | SHEMIN | |
| NPPES Provider FirstName | DOUGLAS | |
| NPPES Provider ZIPCode | 029034923 | |
| NPPES Provider State | RI | |
| Specialty Description | Nephrology | |
| Total Claim Count | 2881.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 169.0 | |
| Percent Opioid Claims | 5.87 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710934724 |
| Last Name Of The Provider | SHEMIN |
| First Name Of The Provider | DOUGLAS |
| View All |
Similar Doctors
|
|
Dr. Andreea Poenariu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Maher, MD |
|
|
Dr. Eric S. Kerns, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George P. Bayliss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayman M. Wahbeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. O'Bell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terri Montague, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fahmeedah S. Kamal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susie L. Hu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Ham, MD |
|
|
Dr. Reginald Y. Gohh, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. William E. Weber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elkin O. Estrada, MD
This Doctor is OpenDoctor Recommended.
|